<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We studied the prognostic value of age and gender by survival, and by standard mortality ratio (SMR) analyses, in 203 untreated patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>); 57 refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> (RA), 23 refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with ringed sideroblasts, 41 refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with excess blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>), 3 RAEB in transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB-T</z:e>) and 79 <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_501'>myelomonocytic leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>), aged 23-89 years (median 69, M/F 0.5), who were <z:hpo ids='HP_0000001'>all</z:hpo> karyotyped </plain></SENT>
<SENT sid="1" pm="."><plain>Median survival was 36 months </plain></SENT>
<SENT sid="2" pm="."><plain>Adverse prognostic factors were: high bone-marrow blast percentage, complex karyotype, <z:hpo ids='HP_0001873'>low platelet count</z:hpo>, age &gt; 60 years, low or high WBC count, <z:chebi fb="34" ids="35143">haemoglobin</z:chebi> &lt; 10 g/dl, male gender </plain></SENT>
<SENT sid="3" pm="."><plain>However, the standard mortality ratio (i.e. mortality compared to that of an age- and sex-adjusted population) was not different between male and female patients </plain></SENT>
<SENT sid="4" pm="."><plain>Patients &lt; 60 had a higher SMR than older patients </plain></SENT>
<SENT sid="5" pm="."><plain>Therefore the prognostic values of age and gender for survival in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients may reflect, at least in part, a characteristic of the population </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, even in low-risk groups defined by scoring system we were unable to define a subgroup of patients with a mortality similar to that of the <z:mpath ids='MPATH_458'>normal</z:mpath> population, especially in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients aged &lt; 60 </plain></SENT>
</text></document>